HEADER TRANSPORT PROTEIN 17-APR-14 4PD7 TITLE STRUCTURE OF VCCNT BOUND TO ZEBULARINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: NUPC FAMILY PROTEIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: VIBRIO CHOLERAE SEROTYPE O1; SOURCE 3 ORGANISM_TAXID: 243277; SOURCE 4 STRAIN: ATCC 39315 / EL TOR INABA N16961; SOURCE 5 GENE: VC_2352; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_CELL_LINE: C41 (DE3); SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET26 KEYWDS MEMBRANE PROTEIN, DRUG TRANSPORTER, SODIUM-COUPLED TRANSPORTER, KEYWDS 2 ZEBULARINE, TRANSPORT PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Z.L.JOHNSON,S.-Y.LEE REVDAT 4 25-DEC-19 4PD7 1 REMARK REVDAT 3 20-SEP-17 4PD7 1 COMPND SOURCE REMARK REVDAT 2 01-OCT-14 4PD7 1 JRNL REVDAT 1 13-AUG-14 4PD7 0 JRNL AUTH Z.L.JOHNSON,J.H.LEE,K.LEE,M.LEE,D.Y.KWON,J.HONG,S.Y.LEE JRNL TITL STRUCTURAL BASIS OF NUCLEOSIDE AND NUCLEOSIDE DRUG JRNL TITL 2 SELECTIVITY BY CONCENTRATIVE NUCLEOSIDE TRANSPORTERS. JRNL REF ELIFE V. 3 03604 2014 JRNL REFN ESSN 2050-084X JRNL PMID 25082345 JRNL DOI 10.7554/ELIFE.03604 REMARK 2 REMARK 2 RESOLUTION. 2.91 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.91 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.22 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.390 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 14932 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.213 REMARK 3 R VALUE (WORKING SET) : 0.211 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 756 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.2209 - 4.9713 1.00 2877 157 0.2171 0.2558 REMARK 3 2 4.9713 - 3.9471 1.00 2848 151 0.1997 0.2505 REMARK 3 3 3.9471 - 3.4485 1.00 2820 149 0.1938 0.2072 REMARK 3 4 3.4485 - 3.1333 1.00 2833 153 0.2175 0.2495 REMARK 3 5 3.1333 - 2.9088 1.00 2798 146 0.2519 0.2787 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 26.210 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 53.69 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.59 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 2976 REMARK 3 ANGLE : 0.676 4039 REMARK 3 CHIRALITY : 0.021 490 REMARK 3 PLANARITY : 0.003 500 REMARK 3 DIHEDRAL : 11.040 1006 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4PD7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 29-APR-14. REMARK 100 THE DEPOSITION ID IS D_1000201077. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-AUG-11 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 9.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0000 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 14952 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.900 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 5.800 REMARK 200 R MERGE (I) : 0.14100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 6.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.90 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.95 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 5.10 REMARK 200 R MERGE FOR SHELL (I) : 0.76600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: 3TIJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 69.81 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.07 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 37-42% PEG 400, 100 MM CACL2, PH 9.5, REMARK 280 LIQUID DIFFUSION, TEMPERATURE 290K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 63 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z REMARK 290 3555 -X+Y,-X,Z REMARK 290 4555 -X,-Y,Z+1/2 REMARK 290 5555 Y,-X+Y,Z+1/2 REMARK 290 6555 X-Y,X,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 41.32900 REMARK 290 SMTRY1 5 0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 5 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 41.32900 REMARK 290 SMTRY1 6 0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 41.32900 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: BIOLOGICAL UNIT IS THE SAME AS ASYM. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 11660 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 43630 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -146.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 -0.866025 0.000000 59.90550 REMARK 350 BIOMT2 2 0.866025 -0.500000 0.000000 -103.75937 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 3 -0.500000 0.866025 0.000000 119.81100 REMARK 350 BIOMT2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 350 BIOMT3 3 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -5 REMARK 465 PRO A -4 REMARK 465 ALA A -3 REMARK 465 VAL A -2 REMARK 465 PRO A -1 REMARK 465 ARG A 0 REMARK 465 MET A 1 REMARK 465 ASN A 230 REMARK 465 GLU A 231 REMARK 465 ASP A 232 REMARK 465 ILE A 233 REMARK 465 THR A 234 REMARK 465 LEU A 235 REMARK 465 ASP A 236 REMARK 465 GLY A 237 REMARK 465 GLY A 238 REMARK 465 ASP A 239 REMARK 465 ASP A 240 REMARK 465 SER A 417 REMARK 465 PHE A 418 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TRP A 51 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 51 CZ3 CH2 REMARK 470 LYS A 85 CG CD CE NZ REMARK 470 GLU A 88 CG CD OE1 OE2 REMARK 470 GLN A 122 CG CD OE1 NE2 REMARK 470 TRP A 123 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 123 CZ3 CH2 REMARK 470 ARG A 126 CG CD NE CZ NH1 NH2 REMARK 470 ILE A 127 CG1 CG2 CD1 REMARK 470 PHE A 164 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LYS A 167 CG CD CE NZ REMARK 470 LYS A 226 CD CE NZ REMARK 470 GLN A 228 CG CD OE1 NE2 REMARK 470 ASP A 229 CG OD1 OD2 REMARK 470 ILE A 284 CG1 CG2 CD1 REMARK 470 PHE A 288 CG CD1 CD2 CE1 CE2 CZ REMARK 470 TRP A 301 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 301 CZ3 CH2 REMARK 470 TRP A 314 CG CD1 CD2 NE1 CE2 CE3 CZ2 REMARK 470 TRP A 314 CZ3 CH2 REMARK 470 ASN A 315 CG OD1 ND2 REMARK 470 GLU A 345 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 23 99.54 -161.54 REMARK 500 VAL A 161 32.62 -140.18 REMARK 500 ILE A 184 -143.96 -117.93 REMARK 500 ALA A 330 -94.07 -131.41 REMARK 500 ALA A 367 93.17 -67.93 REMARK 500 ALA A 383 78.61 -153.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 NA A 502 NA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 149 O REMARK 620 2 ASN A 149 OD1 103.0 REMARK 620 3 VAL A 152 O 83.0 94.5 REMARK 620 4 SER A 183 OG 78.0 87.8 160.9 REMARK 620 5 ILE A 184 O 94.1 159.3 75.8 107.4 REMARK 620 6 HOH A 603 O 162.9 92.7 102.8 96.0 72.2 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue ZE8 A 501 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue NA A 502 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DMU A 503 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3TIJ RELATED DB: PDB REMARK 900 3TIJ CONTAINS THE SAME PROTEIN BOUND TO URIDINE REMARK 900 RELATED ID: 4PB1 RELATED DB: PDB REMARK 900 RELATED ID: 4PD5 RELATED DB: PDB REMARK 900 RELATED ID: 4PB2 RELATED DB: PDB REMARK 900 RELATED ID: 4PD8 RELATED DB: PDB REMARK 900 RELATED ID: 4PD9 RELATED DB: PDB REMARK 900 RELATED ID: 4PDA RELATED DB: PDB DBREF 4PD7 A 1 418 UNP Q9KPL5 Q9KPL5_VIBCH 1 418 SEQADV 4PD7 GLY A -5 UNP Q9KPL5 EXPRESSION TAG SEQADV 4PD7 PRO A -4 UNP Q9KPL5 EXPRESSION TAG SEQADV 4PD7 ALA A -3 UNP Q9KPL5 EXPRESSION TAG SEQADV 4PD7 VAL A -2 UNP Q9KPL5 EXPRESSION TAG SEQADV 4PD7 PRO A -1 UNP Q9KPL5 EXPRESSION TAG SEQADV 4PD7 ARG A 0 UNP Q9KPL5 EXPRESSION TAG SEQRES 1 A 424 GLY PRO ALA VAL PRO ARG MET SER LEU PHE MET SER LEU SEQRES 2 A 424 ILE GLY MET ALA VAL LEU LEU GLY ILE ALA VAL LEU LEU SEQRES 3 A 424 SER SER ASN ARG LYS ALA ILE ASN LEU ARG THR VAL GLY SEQRES 4 A 424 GLY ALA PHE ALA ILE GLN PHE SER LEU GLY ALA PHE ILE SEQRES 5 A 424 LEU TYR VAL PRO TRP GLY GLN GLU LEU LEU ARG GLY PHE SEQRES 6 A 424 SER ASP ALA VAL SER ASN VAL ILE ASN TYR GLY ASN ASP SEQRES 7 A 424 GLY THR SER PHE LEU PHE GLY GLY LEU VAL SER GLY LYS SEQRES 8 A 424 MET PHE GLU VAL PHE GLY GLY GLY GLY PHE ILE PHE ALA SEQRES 9 A 424 PHE ARG VAL LEU PRO THR LEU ILE PHE PHE SER ALA LEU SEQRES 10 A 424 ILE SER VAL LEU TYR TYR LEU GLY VAL MET GLN TRP VAL SEQRES 11 A 424 ILE ARG ILE LEU GLY GLY GLY LEU GLN LYS ALA LEU GLY SEQRES 12 A 424 THR SER ARG ALA GLU SER MET SER ALA ALA ALA ASN ILE SEQRES 13 A 424 PHE VAL GLY GLN THR GLU ALA PRO LEU VAL VAL ARG PRO SEQRES 14 A 424 PHE VAL PRO LYS MET THR GLN SER GLU LEU PHE ALA VAL SEQRES 15 A 424 MET CYS GLY GLY LEU ALA SER ILE ALA GLY GLY VAL LEU SEQRES 16 A 424 ALA GLY TYR ALA SER MET GLY VAL LYS ILE GLU TYR LEU SEQRES 17 A 424 VAL ALA ALA SER PHE MET ALA ALA PRO GLY GLY LEU LEU SEQRES 18 A 424 PHE ALA LYS LEU MET MET PRO GLU THR GLU LYS PRO GLN SEQRES 19 A 424 ASP ASN GLU ASP ILE THR LEU ASP GLY GLY ASP ASP LYS SEQRES 20 A 424 PRO ALA ASN VAL ILE ASP ALA ALA ALA GLY GLY ALA SER SEQRES 21 A 424 ALA GLY LEU GLN LEU ALA LEU ASN VAL GLY ALA MET LEU SEQRES 22 A 424 ILE ALA PHE ILE GLY LEU ILE ALA LEU ILE ASN GLY MET SEQRES 23 A 424 LEU GLY GLY ILE GLY GLY TRP PHE GLY MET PRO GLU LEU SEQRES 24 A 424 LYS LEU GLU MET LEU LEU GLY TRP LEU PHE ALA PRO LEU SEQRES 25 A 424 ALA PHE LEU ILE GLY VAL PRO TRP ASN GLU ALA THR VAL SEQRES 26 A 424 ALA GLY GLU PHE ILE GLY LEU LYS THR VAL ALA ASN GLU SEQRES 27 A 424 PHE VAL ALA TYR SER GLN PHE ALA PRO TYR LEU THR GLU SEQRES 28 A 424 ALA ALA PRO VAL VAL LEU SER GLU LYS THR LYS ALA ILE SEQRES 29 A 424 ILE SER PHE ALA LEU CYS GLY PHE ALA ASN LEU SER SER SEQRES 30 A 424 ILE ALA ILE LEU LEU GLY GLY LEU GLY SER LEU ALA PRO SEQRES 31 A 424 LYS ARG ARG GLY ASP ILE ALA ARG MET GLY VAL LYS ALA SEQRES 32 A 424 VAL ILE ALA GLY THR LEU SER ASN LEU MET ALA ALA THR SEQRES 33 A 424 ILE ALA GLY PHE PHE LEU SER PHE HET ZE8 A 501 16 HET NA A 502 1 HET DMU A 503 33 HETNAM ZE8 ZEBULARINE HETNAM NA SODIUM ION HETNAM DMU DECYL-BETA-D-MALTOPYRANOSIDE HETSYN DMU DECYLMALTOSIDE FORMUL 2 ZE8 C9 H12 N2 O5 FORMUL 3 NA NA 1+ FORMUL 4 DMU C22 H42 O11 FORMUL 5 HOH *3(H2 O) HELIX 1 AA1 LEU A 3 LEU A 20 1 18 HELIX 2 AA2 ASN A 23 ILE A 27 5 5 HELIX 3 AA3 ASN A 28 TYR A 48 1 21 HELIX 4 AA4 VAL A 49 GLY A 79 1 31 HELIX 5 AA5 GLY A 80 SER A 83 5 4 HELIX 6 AA6 GLY A 84 GLY A 91 1 8 HELIX 7 AA7 GLY A 92 PHE A 95 5 4 HELIX 8 AA8 ILE A 96 VAL A 101 1 6 HELIX 9 AA9 VAL A 101 LEU A 118 1 18 HELIX 10 AB1 GLY A 119 GLY A 137 1 19 HELIX 11 AB2 SER A 139 ASN A 149 1 11 HELIX 12 AB3 GLU A 156 VAL A 165 5 10 HELIX 13 AB4 THR A 169 SER A 183 1 15 HELIX 14 AB5 ALA A 185 SER A 194 1 10 HELIX 15 AB6 LYS A 198 MET A 221 1 24 HELIX 16 AB7 ASN A 244 TRP A 287 1 44 HELIX 17 AB8 LYS A 294 ILE A 310 1 17 HELIX 18 AB9 PRO A 313 ASN A 315 5 3 HELIX 19 AC1 GLU A 316 ALA A 330 1 15 HELIX 20 AC2 ASN A 331 ALA A 340 1 10 HELIX 21 AC3 PRO A 341 THR A 344 5 4 HELIX 22 AC4 SER A 352 CYS A 364 1 13 HELIX 23 AC5 LEU A 369 LEU A 382 1 14 HELIX 24 AC6 ALA A 383 LYS A 385 5 3 HELIX 25 AC7 ARG A 386 PHE A 415 1 30 LINK O ASN A 149 NA NA A 502 1555 1555 2.44 LINK OD1 ASN A 149 NA NA A 502 1555 1555 2.43 LINK O VAL A 152 NA NA A 502 1555 1555 2.41 LINK OG SER A 183 NA NA A 502 1555 1555 2.43 LINK O ILE A 184 NA NA A 502 1555 1555 2.39 LINK NA NA A 502 O HOH A 603 1555 1555 2.35 SITE 1 AC1 11 GLN A 154 TYR A 192 ASN A 331 GLU A 332 SITE 2 AC1 11 PHE A 333 PHE A 366 ASN A 368 SER A 371 SITE 3 AC1 11 ILE A 374 HOH A 601 HOH A 602 SITE 1 AC2 5 ASN A 149 VAL A 152 SER A 183 ILE A 184 SITE 2 AC2 5 HOH A 603 SITE 1 AC3 3 ALA A 243 ASN A 244 ALA A 391 CRYST1 119.811 119.811 82.658 90.00 90.00 120.00 P 63 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008346 0.004819 0.000000 0.00000 SCALE2 0.000000 0.009638 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012098 0.00000 MASTER 327 0 3 25 0 0 6 6 0 0 0 33 END